Initial treatment patterns of primary membranoproliferative glomerulonephritis in Japan (2017–2021): an updated analysis based on nationwide personal clinical records
Compared with the earlier report (Report 1), patients with newly registered primary MPGN presented with nephrotic syndrome more often, highlighting the continued risk of poor prognosis and the need for more refined therapeutic approaches.
Authors
- Yoshitaka Isaka (ORCID: https://orcid.org/0000-0002-0820-7167)
- Naoki Nakagawa
- Keiju Hiromura
Institutions
- Osaka Gakuin University (JP)
- Asahikawa Medical College Hospital (JP)
- Asahikawa Medical University (JP)
- Gunma University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Clinical and Experimental Nephrology
- Published
- 2026-02-15
- DOI
- https://doi.org/10.1007/s10157-026-02828-7
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Health, Labour and Welfare